Market Place
Sourcing Support
Bayer, Novartis stack up radiopharmaceutical data at #ESMO21; starts debate
20 Sep 2021 //
ENDPTS
Bayer AG`s Xofigo (radium Ra223 dichloride) Receives Approval in Europe
12 Oct 2018 //
EMA
EMA restricts use of prostate cancer medicine Xofigo
27 Jul 2018 //
EMA
Adempas maker Bayer launches new hypertension support group
14 Jul 2018 //
FIERCE PHARMA
Bayer`s growth-driving quintet? Better, thanks to Stivarga & Xofigo stall
03 May 2018 //
FIERCE PHARMA
What’s killing patients in Bayer’s Xofigo combo study? Researchers halt study
02 Dec 2017 //
ENDPTS
Another record year for Bayer – good progress with the acquisition of Monsanto
23 Feb 2017 //
PRESS RELEASE
Bayer plots Stivarga expansion with new top-line data in hand
05 May 2016 //
FIERCE PHARMA
AZ approval for Tagrisso in Japan a big change to NSCLC treatment option in Asia
30 Mar 2016 //
FIERCE PHARMA ASIA
NHS cancer patients gain access to four new therapies
27 Jan 2016 //
PHARMATIMES
Bayer Presents Latest Xofigo Injection Research at ASCO GU 2016
04 Jan 2016 //
PR NEWS WIRE
NICE OK`s restricted use of Bayer`s prostate cancer drug
19 Nov 2015 //
PHARMATIMES
NICE backs Bayer`s Xofigo but rejects Ferring`s Firmagon
08 Jun 2015 //
PHARMA TIMES
Australia`s Sirtex eyed by Bayer for radioactive attraction?
18 May 2015 //
FIERCE PHARMA ASIA
Strong start to the year for Bayer
01 May 2015 //
WORLD PHARMA NEWS
Drug shortages become issue in Teva and Mylan hook-up
30 Apr 2015 //
FIERCE PHARMA MANUFACTURING
Bayer`s Eylea Cleared for Wider Use in Europe
27 Feb 2015 //
PMLIVE
Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.